Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Differentiation Induction in Acute Myelogenous Leukemia

This study has been completed.
Information provided by (Responsible Party):
Øystein Bruserud, University of Bergen Identifier:
First received: September 9, 2005
Last updated: June 23, 2015
Last verified: June 2015